We're Hopeful That Proteomics International Laboratories (ASX:PIQ) Will Use Its Cash Wisely
May 10
Australian (ASX) Clinical Research and Equipment Industry Analysis
UpdatedMay 31, 2023
DataAggregated Company Financials
Companies9
- 7D1.1%
- 3M-18.9%
- 1Y-44.7%
- YTD-21.8%
In the last week, the Clinical Research and Equipment industry is up 1.1%, with AnteoTech up 7.5%. In the same time, Trajan Group Holdings was down 6.0%. In the past year, the industry is down 45%. Earnings are forecast to grow by 43% annually.
Industry Valuation and Performance
Has the Australian Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|
Loading
Current Industry PE
- Investors are pessimistic on the Australian Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 9.6x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 51% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Comparison
How does Australian Clinical Research and Equipment compare with similar industries?
| AU Market | -0.81% | |
| Healthcare | -0.43% | |
| Life Sciences | 1.06% | |
| Clinical Research and Equipment | 1.06% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ADO AnteoTech | AU$0.043 | 7.5% +AU$6.1m | -57.0% | PS45.4x | |
| EZZ EZZ Life Science Holdings | AU$0.57 | 10.6% +AU$2.3m | 59.7% | PE9.8x | |
| PIQ Proteomics International Laboratories | AU$0.97 | 1.0% +AU$1.2m | -1.5% | PS33x |
